ОбзорГрафикНовостиTraderScreen

Morgan Stanley Knock-Out AMGN/  DE000MB8ULR4  /

Stuttgart
28.06.2024  21:23:35 Изменение- Бид8:58:36 Предложение8:58:36 Базовый актив Цена исполнения Дата истечения Тип опциона
10.48EUR - 10.60
Величина цены спроса: 750		 10.72
Величина цены предложения: 750		 Amgen Inc 199.0041 USD 31.12.2078 Call
TeleTrader 9:04 CAC 40 soars 2.5% after far-right election dominance
GlobeNewswire 9:00 Sportradar Secures Major Client Wins on Strength of Managed Trading Services
Newsfile Corp 9:00 LBank Exchange Will List SEKAI (M) on July 2, 2024
GlobeNewswire 8:34 Leading Financial Markets Lawyer Ciarán McGonagle Joins Tokenovate as Chief Legal and Product Office...
TeleTrader 8:31 Swiss retail sales fall by 0.3% in May
TeleTrader 8:30 French far-right wins first round with 33.15%, final results show
TeleTrader 8:29 UK annual house price growth at 1.5% in June
Newsfile Corp 8:28 Mer1992Dan Transit(TM) Inc. Expands Fleet to Meet Increasing Demands
TeleTrader 8:12 Israel releases Al Shifa Hospital director from custody
TeleTrader 8:08 Israeli army says 20 rockets fired from Gaza
GlobeNewswire 8:03 FDA Approves PYZCHIVA® (ustekinumab-ttwe), Samsung Bioepis’ Biosimilar to Stelara
TeleTrader 8:01 Europe rises in premarket after French election
GlobeNewswire 8:00 Caledonia declares quarterly dividend
GlobeNewswire 8:00 Bedford Metals Completes Satellite Survey at Ubiquity Lake Uranium Project
GlobeNewswire 8:00 FF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that FutureFuel Corp. Investors with ...
GlobeNewswire 8:00 GHO Capital realises significant return with sale of FairJourney Biologics
GlobeNewswire 8:00 Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA
GlobeNewswire 8:00 EUR 1.535 billion share buyback completed
GlobeNewswire 8:00 LIfT BioSciences appoints Antonin (Tony) de Fougerolles as Chairman of its Board of Directors
GlobeNewswire 7:55 Mesoblast to File Biologics License Application for Ryoncil® FDA Approval Next Week
TeleTrader 7:46 Boeing to buy Spirit AeroSystems in $4.7B deal
GlobeNewswire 7:45 Sword Group: Acquisitions in the UK
GlobeNewswire 7:30 Atlas Luxco S.à r.l., a subsidiary of Atlas Investissement S.A.S., announces public offers to purcha...
GlobeNewswire 7:30 OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in A...
TeleTrader 7:24 Asian markets mixed as Japan's GDP slows